Respiratorius AB - Product Pipeline Review - 2015

Published: Dec, 2015 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Respiratorius AB - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Respiratorius AB - Product Pipeline Review - 2015', provides an overview of the Respiratorius AB's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Respiratorius AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Respiratorius AB including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Respiratorius AB's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Respiratorius AB's pipeline products

Reasons to Buy

- Evaluate Respiratorius AB's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Respiratorius AB in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Respiratorius AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Respiratorius AB and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Respiratorius AB
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Respiratorius AB and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Respiratorius AB Snapshot 4
Respiratorius AB Overview 4
Key Information 4
Key Facts 4
Respiratorius AB - Research and Development Overview 5
Key Therapeutic Areas 5
Respiratorius AB - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Respiratorius AB - Pipeline Products Glance 9
Respiratorius AB - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase 0 Products/Combination Treatment Modalities 10
Respiratorius AB - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Respiratorius AB - Drug Profiles 12
valproate sodium 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
RESP-1000 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
RESP-2000 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Respiratorius AB - Pipeline Analysis 15
Respiratorius AB - Pipeline Products by Target 15
Respiratorius AB - Pipeline Products by Route of Administration 16
Respiratorius AB - Pipeline Products by Molecule Type 17
Respiratorius AB - Pipeline Products by Mechanism of Action 18
Respiratorius AB - Recent Pipeline Updates 19
Respiratorius AB - Dormant Projects 20
Respiratorius AB - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables

Respiratorius AB, Key Information 4
Respiratorius AB, Key Facts 4
Respiratorius AB - Pipeline by Indication, 2015 6
Respiratorius AB - Pipeline by Stage of Development, 2015 7
Respiratorius AB - Monotherapy Products in Pipeline, 2015 8
Respiratorius AB - Phase II, 2015 9
Respiratorius AB - Phase 0, 2015 10
Respiratorius AB - Preclinical, 2015 11
Respiratorius AB - Pipeline by Target, 2015 15
Respiratorius AB - Pipeline by Route of Administration, 2015 16
Respiratorius AB - Pipeline by Molecule Type, 2015 17
Respiratorius AB - Pipeline Products by Mechanism of Action, 2015 18
Respiratorius AB - Recent Pipeline Updates, 2015 19
Respiratorius AB - Dormant Developmental Projects,2015 20
Respiratorius AB, Subsidiaries 21